|Articles|May 15, 2002
A versatile product: FDA approves botulinum toxin for glabellar lines
Irvine, CA-The FDA has approved the use of botulinum toxin type A (Botox, Allergan, Irvine, CA) for temporary improvement in the appearance of moderate to severe glabellar lines in adult men and women 65 or younger.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Closing the gap: John Berdahl, MD, on the global cataract burden and the emerging dementia connection
2
Oculis phase 3 DIAMOND trials miss vision endpoints in diabetic macular edema
3
FDA guidance to help accelerate cell and gene therapies
4
TearSolutions advances Lacripep into phase 2 following dual FDA designations in neurotrophic keratitis
5

















